These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 17251074)
1. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. Hamada Y; Kitazawa S; Kitazawa R; Fujii H; Kasuga M; Fukagawa M Bone; 2007 May; 40(5):1408-14. PubMed ID: 17251074 [TBL] [Abstract][Full Text] [Related]
2. Role of oxidative stress in diabetic bone disorder. Hamada Y; Fujii H; Fukagawa M Bone; 2009 Jul; 45 Suppl 1():S35-8. PubMed ID: 19232402 [TBL] [Abstract][Full Text] [Related]
3. Amylin and bone metabolism in streptozotocin-induced diabetic rats. Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342 [TBL] [Abstract][Full Text] [Related]
4. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Hamada Y; Fukagawa M Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205 [TBL] [Abstract][Full Text] [Related]
5. Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences. Shrilatha B; Muralidhara Reprod Toxicol; 2007 Jun; 23(4):578-87. PubMed ID: 17360155 [TBL] [Abstract][Full Text] [Related]
6. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat. Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444 [TBL] [Abstract][Full Text] [Related]
7. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Hamada Y; Fujii H; Kitazawa R; Yodoi J; Kitazawa S; Fukagawa M Bone; 2009 May; 44(5):936-41. PubMed ID: 19146996 [TBL] [Abstract][Full Text] [Related]
9. Vitamin K₂ prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetes. Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK Calcif Tissue Int; 2011 Feb; 88(2):162-8. PubMed ID: 21136047 [TBL] [Abstract][Full Text] [Related]
10. An in vivo experimental study on osteopenia in diabetic rats. Musumeci G; Loreto C; Clementi G; Fiore CE; Martinez G Acta Histochem; 2011 Oct; 113(6):619-25. PubMed ID: 20696468 [TBL] [Abstract][Full Text] [Related]
11. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Yang P; Zhao Z; Reece EA Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327 [TBL] [Abstract][Full Text] [Related]
12. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia. Hadjidakis D; Lempert UG; Minne HW; Ziegler R Horm Metab Res; 1993 Feb; 25(2):77-81. PubMed ID: 8458612 [TBL] [Abstract][Full Text] [Related]
13. Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. Liang W; Luo Z; Ge S; Li M; Du J; Yang M; Yan M; Ye Z; Luo Z Eur J Pharmacol; 2011 Nov; 670(1):317-24. PubMed ID: 21914440 [TBL] [Abstract][Full Text] [Related]
14. Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin-diabetic rat. Shrilatha B; Int J Androl; 2007 Dec; 30(6):508-18. PubMed ID: 17573857 [TBL] [Abstract][Full Text] [Related]
15. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Somfai GM; Knippel B; Ruzicska E; Stadler K; Tóth M; Salacz G; Magyar K; Somogyi A Neurochem Int; 2006 Jun; 48(8):746-52. PubMed ID: 16524643 [TBL] [Abstract][Full Text] [Related]
16. Alterations in femoral bone histomorphometry and vitamin D metabolism in neonatal streptozotocin-induced diabetic rat. Umeda F; Inoue K; Hirano K; Mimura K; Watanabe J; Haji M; Sueishi K; Nawata H Fukuoka Igaku Zasshi; 1992 Nov; 83(11):403-8. PubMed ID: 1336471 [TBL] [Abstract][Full Text] [Related]
17. [Bone histomorphometric osteopenia induced by ovariectomy or diabetes mellitus in rat]. Nagasawa T Nihon Seikeigeka Gakkai Zasshi; 1995 Sep; 69(9):699-707. PubMed ID: 8530885 [TBL] [Abstract][Full Text] [Related]
18. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. Rupérez FJ; García-Martínez D; Baena B; Maeso N; Cifuentes A; Barbas C; Herrera E J Pharm Pharmacol; 2008 Jul; 60(7):871-8. PubMed ID: 18549673 [TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice. Kim MJ; Kim HK Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392 [TBL] [Abstract][Full Text] [Related]